Though the Pfizer vaccine in this study was more likely to cause subclinical axillary LAD, as a greater proportion of patients who received the vaccine developed sLAD (13.2% of all Pfizer vaccine recipients vs 9.5% of all Moderna recipients), the data shows a trend towards significance that Moderna may be more likely to cause lymphadenopathy in the elderly.
← all excerpts
COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
1
—
—